Exponent Inc

Análisis de la acción Exponent Inc (EXPO)

$77.430

+0.317 (+0.41%)Al cierre

Loading chart…
Máximo
77.690
Apertura
76.560
Precio medio ponderado por volumen
76.94
Volumen
377.80K
Capitalización
4.85B
Mínimo
75.700
Importe
29.07M
EV/EBITDA, TTM
27.22

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.

www.exponent.com

Análisis de IA of Exponent Inc (EXPO)

Comprar

Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $77.43 and a recent RSI of 91.863 indicating strong momentum. The company reported a 20.9% year-over-year revenue growth in Q2, reaching $171.61 million, which exceeded market expectations. Additionally, the forward P/E ratio is 31.55, suggesting reasonable valuation compared to its growth prospects. However, the main risk is the recent downgrade from UBS, lowering their price target to $72, which could indicate potential volatility ahead.

Recomendaciones de analistas (4)

+10.42% de potencial alcista
Mantener
1 Comprar
3 Mantener
0 Vender
Actual: 77.43
Mínimo
81.00
Promedio
85.50
Máximo
90.00

UBS

2026-07-31

Precio objetivo

$72

Neutral

JPMorgan

2026-07-31

Precio objetivo

$90

Sobreponderar

JPMorgan

2026-05-15

Precio objetivo

$80

Sobreponderar

UBS

2026-05-01

Precio objetivo

$75

Neutral

JPMorgan

2026-03-26

Precio objetivo

$95

Sobreponderar

Métricas de valoración

El PER previsto actual de Exponent Inc (EXPO) es 31.55, frente a su media de 5 años de 42.53.

PER previsto

Infravalorado
Media 5A P/E
42.53
P/E actual
31.55
Sobrevalorada
51.44
Infravalorada
33.61

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
29.66
EV/EBITDA actual
27.22
Sobrevalorada
36.57
Infravalorada
22.75

Precio/ventas previsto

Infravalorado
Media 5A P/S
8.47
P/S actual
5.52
Sobrevalorada
10.70
Infravalorada
6.24

Escenarios de precio de Alphio AI para EXPO

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%EXPO

$68.96

Precio del escenario

B

Base

Base · 50%EXPO

$67.10

Precio del escenario

B

Bajista

Bajista · 25%EXPO

$58.23

Precio del escenario

Ballenas con EXPO en cartera

R

Roffman Milller Associates Inc

+ Con en carteraEXPO

+1.62%

Rentabilidad a 3 meses

R

Royce & Associates, LP

+ Con en carteraEXPO

-17.34%

Rentabilidad a 3 meses

Cronología de eventos

2026-07-30 (ET)

17:00:00

Exponent Increases Share Repurchase Authorization by $50M

16:30:00

Company Raises FY26 Adjusted EBITDA Outlook to 27.8%-28.1%

16:30:00

Exponent Reports Q2 Revenue of $148.86M

16:30:00

Exponent Sees Q3 Adjusted EBITDA at 28%-28.5% of Revenue

2026-04-30 (ET)

17:10:00

Exponent's Board Increases Share Repurchase Authority by $50M

Noticias

Preguntas frecuentes sobre EXPO, respondidas por Alphio AI

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $77.43 and a recent RSI of 91.863 indicating strong momentum. The company reported a 20.9% year-over-year revenue growth in Q2, reaching $171.61 million, which exceeded market expectations. Additionally, the forward P/E ratio is 31.55, suggesting reasonable valuation compared to its growth prospects. However, the main risk is the recent downgrade from UBS, lowering their price target to $72, which could indicate potential volatility ahead.

4 analysts cover EXPO: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 85.50.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar